CMV pp65 Mouse Monoclonal Antibody [Clone ID: CMV101]

Specifications

Product Data
Clone Name	CMV101
Applications	IF, IHC
Recommend Dilution	ELISA: Use BSA free Antibody for Coating. Immunofluorescence: 0.5-1 μg/ml. Immunocytochemistry on Acetone or Paraformaldehyde Fixed Sections: 0.5-1.0 μg/ml for 30 minutes at RT. Positive Control: CMV-infected cells or tissues.
Reactivity	Cytomegalovirus
Host	Mouse
Clonality	Monoclonal
Immunogen	Recombinant CMV-p65 protein.
Specificity	Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, CMV is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of CMV disease. An indicator of active CMV i nfection is needed to facilitate the diagnosis of CMV disease in patients with AIDS or HIV in fection. CMV p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. Cellular Localization: Nuclear.
Formulation	10mM PBS State: Purified State: Liquid purified IgG fraction from Bioreactor Concentrate Stabilizer: 0.05% BSA Preservative: 0.05% Sodium Azide
Concentration	lot specific
Purification	Protein A/G Chromatography
Conjugation	Unconjugated
Storage Condition	Store undiluted at 2-8°C.
Predicted Protein Size	65 kDa
Synonyms	CMV-p65, Cytomegalovirus
Reference Data

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.